U.S. RESEARCH ROUNDUP-Eli Lilly, Gilead Sciences, Upwork
23/05/2022 08:14
May 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Eli Lilly, Gilead Sciences and Upwork, on Monday.
HIGHLIGHTS
* Eli Lilly LLY.N : SVB Securities starts coverage with outperform rating; PT $341
* Gilead Sciences Inc GILD.O : SVB Securities starts coverage with market perform rating
* Halozyme Therapeutics Inc HALO.O : SVB Securities starts coverage with outperform rating
* Radius Health Inc RDUS.O : SVB Securities starts coverage with market perform rating
* Upwork Inc UPWK.O : RBC starts with sector perform rating; $21 target price
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
* Abbvie Inc ABBV.N : SVB Securities starts coverage with underperform rating; PT $140
* Aeglea Bio Therapeutics Inc AGLE.O : Piper Sandler cuts target price to $4 from $7
* Amgen Inc AMGN.O : SVB Securities starts coverage with market perform rating; PT $256
* Anterix Inc ATEX.O : JP Morgan cuts target price to $68 from $71
* Arvinas Inc ARVN.O : Piper Sandler cuts target price to $76 from $116
* Autodesk Inc ADSK.O : RBC cuts target price to $255 from $295
* Avalonbay Communities Inc AVB.N : JP Morgan cuts target price to $246 from $262
* Avantor Inc AVTR.N : Jefferies cuts target price to $40 from $45
* Cheniere Energy Inc LNG.A : RBC raises target price to $178 from $151
* Cheniere Energy Partners LP CQP.A : RBC raises target price to $54 from $52
* Chimera Investment Corp CIM.N : RBC cuts target price to $11 from $15
* Covenant Logistics Group Inc CVLG.O : Cowen and Company raises target to $22 from $21
* Curo Group Holdings Corp CURO.N : Stephens cuts target price to $13 from $22
* Deere & Co DE.N : JP Morgan cuts target price to $370 from $440
* Domo Inc DOMO.O : Cowen and Company cuts target price to $70 from $85
* Dyne Therapeutics Inc DYN.O : Piper Sandler cuts target price to $12 from $16
* Eagle Materials Inc EXP.N : Truist Securities cuts target price to $155 from $172
* Edgewise Therapeutics Inc EWTX.O : JP Morgan cuts target price to $28 from $32
* Eli Lilly LLY.N : SVB Securities starts coverage with outperform rating; PT $341
* Eloxx Pharmaceuticals Inc ELOX.O : Piper Sandler cuts target price to $1.50 from $4
* Fate Therapeutics Inc FATE.O : Piper Sandler cuts target price to $71 from $113
* Foot Locker Inc FL.N : Cowen and Company raises target price to $35 from $34
* Foot Locker Inc FL.N : Credit Suisse raises target price to $32 from $30
* Foot Locker Inc FL.N : Jefferies cuts target price to $50 from $61
* Foot Locker Inc FL.N : JP Morgan raises target price to $28 from $26
* Gilead Sciences Inc GILD.O : SVB Securities starts coverage with market perform rating
* Gilead Sciences Inc GILD.O : SVB Securities starts coverage with target price $68
* Halozyme Therapeutics Inc HALO.O : SVB Securities starts coverage with outperform rating
* Halozyme Therapeutics Inc HALO.O : SVB Securities starts coverage with target price $52
* Infinity Pharmaceuticals Inc INFI.O : Piper Sandler cuts target price to $3 from $4
* J&J JNJ.N : SVB Securities assumes coverage with outperform rating; target price $200
* Jounce Therapeutics Inc JNCE.O : Piper Sandler cuts target price to $9 from $17
* Kronos Bio Inc KRON.O : Piper Sandler cuts target price to $13 from $30
* Kymera Therapeutics Inc KYMR.O : Piper Sandler cuts target price to $43 from $91
* Maravai Lifesciences Holdings Inc MRVI.O : Jefferies cuts target price to $40 from $43
* Mettler-Toledo International Inc MTD.N : Jefferies cuts target to $1,275 from $1,475
* Monro Inc MNRO.O : Stephens cuts target price to $41 from $47
* Nextcure Inc NXTC.O : Piper Sandler cuts target price to $13 from $21
* Nvidia Corp NVDA.O : Bernstein cuts target price to $225 from $325
* Omega Therapeutics Inc OMGA.O : Piper Sandler cuts target price to $7 from $30
* ONEOK Inc OKE.N : RBC raises target price to $69 from $68
* Pfizer Inc PFE.N : SVB Securities starts coverage with market perform rating; PT $55
* Primo Water Corp PRMW.N : Jefferies cuts target price to $19 from $21
* Radius Health Inc RDUS.O : SVB Securities starts coverage with market perform rating
* Radius Health Inc RDUS.O : SVB Securities starts coverage with target price $7
* Redwire Corp RDW.N : Jefferies cuts target price to $11 from $13
* Regeneron Pharmaceuticals REGN.O : SVB Securities starts coverage with outperform rating
* Regeneron Pharmaceuticals REGN.O : SVB Securities starts coverage with target price $738
* Ross Stores Inc ROST.O : Cowen and Company cuts target price to $81 from $108
* Salesforce Inc CRM.N : Cowen and Company cuts target price to $225 from $285
* Seres Therapeutics Inc MCRB.O : Piper Sandler cuts target price to $7 from $32
* Snowflake Inc. SNOW.N : Cowen and Company cuts target price to $280 from $390
* Splunk Inc SPLK.O : Cowen and Company cuts target price to $110 from $130
* Sportradar Group AG SRAD.O : Jefferies cuts target price to $18 from $23
* Sumo Logic Inc SUMO.O : RBC cuts target price to $14 from $17
* Sutro Biopharma Inc STRO.O : Piper Sandler cuts target price to $14 from $29
* Target Corp TGT.N : Credit Suisse cuts target price to $180 from $286
* Teleflex Inc TFX.N : RBC cuts target price to $380 from $390
* Upwork Inc UPWK.O : RBC starts with sector perform rating; $21 target price
* Vertex Pharmaceuticals Inc VRTX.O : SVB Securities starts with market perform rating
* Vertex Pharmaceuticals Inc VRTX.O : SVB Securities starts with target price $265
* VMware Inc VMW.N : RBC cuts target price to $140 from $153
* Williams-Sonoma Inc WSM.N : JP Morgan cuts target price to $120 from $160
* Workday Inc WDAY.O : Cowen and Company cuts target price to $250 from $310
* Workday Inc WDAY.O : Jefferies cuts target price to $220 from $350
* Xencor Inc XNCR.O : Piper Sandler cuts target price to $42 from $66
* Zscaler Inc ZS.O : RBC cuts target price to $200 from $330
* Zuora Inc ZUO.N : Jefferies cuts target price to $11 from $17
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence